Zotefoams Plc Regulatory News (ZTF)

Zotefoams plc

("Zotefoams" or "Group")

Trading Update

Continued positive momentum through Q3 and full year expectations increased

13 October 2022 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the nine months ended 30 September 2022 ("year to date") and in respect of its financial year ending 31 December 2022.

Zotefoams is pleased to report a record third quarter sales performance, with Group revenues approximately 27% ahead of Q3 2021 which was its previous record third quarter. As a result, year to date Group revenue is approximately 24% ahead of the comparable period last year.

Current trading

Encouragingly, the Group continues to benefit from its broad customer diversification and has seen continued resilient demand across most of its end market segments. Both revenues and margins are also seeing an increasing benefit from pricing actions implemented earlier in the year, in response to cost inflation, as well as from a weaker Sterling exchange rate, primarily against the US dollar.

Reflecting this commercial backdrop, each of the Group's three business segments has delivered solid progress year to date with sales having increased by approximately:

Input cost inflation, other than energy prices, has seen some recent abatement, with commodity polymer prices declining from all-time high levels experienced late in the first half of this year. Wholesale energy prices remain volatile but, in the UK, which accounts for the majority of Group energy consumption, the short-term risk associated with energy pricing has been reduced due to Government pricing actions.

As described above, the Group has seen some benefit from Sterling weakness, albeit the impact of exchange rate movements on both sales and costs has been hedged in accordance with its hedging policy.

Good progress has been made on strategic initiatives, including the development of ReZorce, as well as the Group's wider ESG focus on reducing Scope 1 and 2 carbon emissions and launching foams with recycled content.

Outlook

Demand entering the final quarter remains encouraging and we have good visibility of confirmed orders for the remainder of 2022.

Based on its current sales forecasts and foreign exchange rates, and subject to there being no material disruption to the business, the Board now expects adjusted profit before income tax to be significantly ahead of market expectations*.

Cash generation also continues to be strong and so the better than anticipated earnings performance should contribute to an appreciable reduction in both net debt and leverage.

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"I am delighted that Zotefoams is performing well in this volatile market environment which is a credit to our people, market positioning and strategy. Our exposure to a wide range of attractive markets has enabled us to deliver continued volume growth, which has been supported by the pricing actions taken earlier in the year.

We are mindful of the challenging backdrop but continue to see significant opportunity for the Group in both the short and longer term." 

* Current Company-compiled consensus expectations for adjusted profit before income tax and separately disclosed items, for the year ending 31 December 2022, is £9.3m.

- Ends -

Enquiries:

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com